Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06315673 · ClinicalTrials.gov registry record
Digital Assessment of Speech and Fine Motor Control in ALS
A clinical trial of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06315673 is a study of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 50 participants, below the 897-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06315673, a study of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-session, case-control study that incorporates digital tools for assessing speech and motor function in motor neuron disease. Patients with motor neuron disease (including amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), and progressive muscular atrophy (PMA)) and age-matched healthy controls will be enrolled. Subjects will complete a speech and handwriting assessment during the study visit on a tablet computer (BioSensics LLC, Newton, MA). We will explore whether these digital biomarkers are sensitive to functional disease severity as reported by the ALS Functional Rating Scale - Revised (ALFRS-R) \[1\]. We will also compare assessment data between the patient and control groups.
Conditions Studied
Interventions
- BEHAVIORAL Digital Speech and Handwriting Assessment
Study Locations (1)
Pennsylvania
- Milton S. Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2027-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06315673
The ClinicalTrials.gov registry entry for NCT06315673 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 897-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (94% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Digital Speech and Handwriting Assessment is the first listed.
NCT06315673 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06315673 about?
NCT06315673 is a clinical study titled "Digital Assessment of Speech and Fine Motor Control in ALS". This is a single-session, case-control study that incorporates digital tools for assessing speech and motor function in motor neuron disease. Patients with motor neuron disease (including amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), and progressive muscular atrophy (PMA)) an...
What is the current status of trial NCT06315673?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-07-01. Estimated completion is 2027-03-30.
What conditions does trial NCT06315673 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, Progressive Muscular Atrophy.
What interventions are being tested in trial NCT06315673?
The interventions under investigation include: Digital Speech and Handwriting Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06315673?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06315673 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
PREVENT ALL ALS Study
RECRUITING
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Explore more on PlainTrial
Amyotrophic Lateral Sclerosis
All registered trials for this condition
Primary Lateral Sclerosis
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.